PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA
Clinical trials for PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for aggressive lymphoma in young patients
Disease control OngoingThis study tests whether giving a targeted drug (ibrutinib) plus an immunotherapy (rituximab) before standard chemotherapy can improve outcomes for young patients with newly diagnosed mantle cell lymphoma, an aggressive blood cancer. About 131 participants will receive the combin…
Matched conditions: PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
New drug combo shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests two drugs, venetoclax and acalabrutinib, given together to people with mantle cell lymphoma that came back or didn't respond to prior therapy. The goal is to see if the combination can shrink or eliminate cancer. 32 adults with this specific blood cancer are part…
Matched conditions: PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:57 UTC